ArticleRevista peruana de medicina experimental y salud publica2026
Altitude and case fatality rate from COVID-19 during the pandemic in Peru, 2020-2022.
Article in Revista peruana de medicina experimental y salud publica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Objectives: To evaluate the functional form of the association between the district altitude of residence and the case fatality rate of COVID-19 cases in Peru during the 2020-2022 period. Materials and methods: A retrospective cohort study was conducted using secondary data from the Ministry of Health of Peru on COVID-19 cases and deaths. District altitude of residence was categorized into four groups (0-500; 501-2,000; 2,001-3,500; and ≥3,501 masl). The outcome was death from COVID-19 according to the official death registry. Poisson regression was used to estimate adjusted relative risks for individual and contextual variables, using robust variance clustered by district. The analyses were repeated according to the five epidemic waves that occurred between March 2020 and December 2022. Results: A non-linear association was observed between the altitude of residence and death from COVID-19, consistent with a "U-shaped" pattern, characterized by a lower risk of death in cases residing between 2,001 and 3,500 masl compared to those residing between 0 and 500 masl. This pattern remained consistent in the analyses stratified by epidemic wave. Conclusions: In Peru, during the 2020-2022 period, the data do not support a monotonic decrease in the risk of death from COVID-19 with increasing altitude of residence. On the contrary, the results suggest a non-linear relationship, with lower lethality at intermediate altitudes (2,001-3,500 masl).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.